Opinion|Videos|August 16, 2024
Personalizing Treatment Selection
A key opinion leader in dermatology explains how the presence of type 2 inflammation informs their treatment decisions for atopic dermatitis and prurigo nodularis, while also detailing additional patient-specific factors such as age, comorbidities, and disease severity that influence their therapeutic approach.
Advertisement
Episodes in this series
- How does knowing that type 2 inflammation is a cause influence your treatment selection?
- Beyond identifying the underlying cause, what other patient-specific factors (e.g., age, comorbidities, disease severity) do you consider when selecting treatment regimens for AD or PN?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
